ISSX Honors Members with North American Awards
Wednesday, August 13, 2014
2025 M Street NW
Washington, DC 20036
Tel. + 1 (202) 367-1160
Fax + 1 (202) 367-2160
CONTACT: Steven C. Kemp, CAE
FOR IMMEDIATE RELEASE
9 A.M. EDT, August 14, 2014
OUTSTANDING SCIENTISTS SELECTED TO RECEIVE PRESTIGIOUS AWARDS
WASHINGTON, DC, August 14, 2014: The International Society for the Study of Xenobiotics (ISSX) announced the winners today of its most prestigious awards presented to outstanding scientists in the North American Region. Thomas A. Baillie, Ph.D. of the University of Washington was selected for the North American Scientific Achievement Award, in Honor of Ronald W. Estabrook. Nina Isoherranen, Ph.D., also of the University of Washington, was selected for the North American New Investigator Award, in Honor of James R. Gillette.
Dr. Baillie is Professor of Medicinal Chemistry and Dean of the School of Pharmacy at the University of Washington in Seattle, Washington. He has made major contributions to the understanding of the metabolism of xeno- and endobiotics and is internationally recognized for his seminal contributions in this area of scientific research. Dr. Baillie trained in Scotland and Sweden and began his academic career at the University of London. He later joined the faculty at the University of California at San Francisco and then at the Berkeley campus. He next spent sixteen years at the University of Washington School of Pharmacy before joining Merck as head of their drug metabolism research team. In 2008, Dr. Baillie returned to the University of Washington as Dean of the School of Pharmacy. Said one of his nominators, Dr. Paul Ortiz de Montellano of the University of California, San Francisco, School of Pharmacy, “Tom Baillie is an internationally recognized scientist who continues to flourish and to have a broad impact on the field of drug metabolism. In my mind, he epitomizes the International Society for the Study of Xenobiotics in that he represents the conjunction of basic, academic research with a concern for the role of drug metabolism in the development of new and safer therapeutics.”
Dr. Nina Isoherranen earned a Ph.D. in pharmaceutical sciences at the Hebrew University of Jerusalem, Israel and completed postdoctoral training at the University of Washington School of Pharmacy in the Department of Pharmaceutical Sciences. She was promoted to faculty in 2006 and achieved the position of Association Professor with tenure in 2012. During this time, Dr. Isoherranen has become recognized in the fields of drug metabolism and pharmacokinetics through the establishment of a diverse and productive research program. The overall theme of Dr. Isoherranen’s research has been the application of in-vitro enzymology and enzyme kinetics knowledge to clinical pharmacokinetics problems. According to Professor Edward T. Morgan of Emory University who serves as Editor of Drug Metabolism and Disposition, “Key attributes that define the most successful and impactful researchers are breadth, scientific acumen, and good judgment. Dr. Isoherranen has all of these. She is a rising star in the drug metabolism field.”
The North American Scientific Achievement Award and the North American New Investigator Award will be presented at the 19th North American ISSX Meeting at a special session on October 21. ISSX Awards Committee Chairman, Dr. Geoffrey T. Tucker, Emeritus Professor of Clinical Pharmacology at the University of Sheffield, UK, will present the awards which will be followed by scientific lectures by both awardees. The ISSX North American Scientific Achievement Award in Honor of Ronald W. Estabrook is sponsored by XenoTech, LLC. The 19th North American ISSX Meeting will be held jointly with the 29th Annual Meeting of the Japanese Society for the Study of Xenobiotics and will convene October 18 - 23, 2014 at the Hilton Union Square San Francisco Hotel in San Francisco, California.
Headquartered in Washington, DC, ISSX is an international association of scientists that promotes the understanding of the interactions of medicines and chemicals with living systems. Founded in 1981, ISSX conducts scientific meetings worldwide to foster greater understanding of the research being conducted to develop and improve therapeutics and to form collaborations between scientists involved in this area of study.
The goals of the Society are to:
To facilitate and encourage the assembly, acquaintanceship and association of scientists engaged in research in xenobiotic metabolism and in other related disciplines.
To disseminate, discuss and publish results of research and related matters of interest in metabolism.
To promote public awareness of chemical metabolism and its social and environmental implications.
To promote education and training in the field.
Visit www.issx.org for more information.